Abstract |
5-Azacytidine (azaC) has previously been shown to raise Hb F levels in the repeatedly phlebotomized baboon (PCV: around 20%). The administration of tetrahydrouridine (THU), an inhibitor of the enzymatic conversion of azaC to 5-azauridine, made it possible to reduce the amount of azaC and also of 2-deoxy-5-azacytidine (d-azaC) by more than 90% and still achieve maximal Hb F elevations. However, the granulocytopenia, usually occurring after 5-azaC, was not altered by the lowering of the dosages in the presence of THU. Thus, the granulocytopenia is not due to 5-azauridine or other catabolic products resulting from deamination. It is also unlikely that it is caused by a direct influence of azaC on RNA since d-azaC also causes granulocytopenia. The persistence of reticulocytosis throughout the treatment with azaC or d-azaC makes it appear likely that the observed increase in Hb F levels to more than 60% of total hemoglobin is not due to a cytotoxic effect on erythropoiesis resulting in a shift of cell populations toward greater immaturity, but to a direct influence of the drug on the regulation of gamma globin chain production.
|
Authors | J DeSimone, P Heller, R E Molokie, L Hall, D Zwiers |
Journal | American journal of hematology
(Am J Hematol)
Vol. 18
Issue 3
Pg. 283-8
(Mar 1985)
ISSN: 0361-8609 [Print] United States |
PMID | 2579548
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Tetrahydrouridine
- Decitabine
- Globins
- Fetal Hemoglobin
- Cytidine Deaminase
- Azacitidine
- Uridine
|
Topics |
- Agranulocytosis
(etiology)
- Animals
- Azacitidine
(analogs & derivatives, pharmacology, toxicity)
- Cytidine Deaminase
(antagonists & inhibitors)
- Decitabine
- Fetal Hemoglobin
(biosynthesis, genetics)
- Gene Expression Regulation
(drug effects)
- Globins
(genetics)
- Granulocytes
(enzymology)
- Papio
- Tetrahydrouridine
(pharmacology)
- Uridine
(analogs & derivatives)
|